UGER ROBERT (Chief Scientific Officer) sold 584.00 shares of TRILLIUM THERAPEUTICS INC. on the open market
Open‑market sale worth $8.9K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/13/2021ACC: 0001062993-21-000340
Officer· Chief Scientific Officer
Since Jan 2021
-584.00
Net shares
Net seller
$8.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
584.00 acquired · 1.17K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+584.00
Price / share
$9.57
Trade value
$5.59K
% of position
New position
1/11/2021
0.00→584.00
Common Shares
Direct
Shares
−584.00
Price / share
$15.20
Trade value
$8.88K
% of position
New position
1/11/2021
584.00→0.00
Total
Net shares
+0.00
Net value
-$3.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/11/2021 | M · Option Exercise | +584.00 | $9.57 | $5.59K | New position | 0.00 | 584.00 |
| Common Shares Direct | 1/11/2021 | S · Sale | −584.00 | $15.20 | $8.88K | New position | 584.00 | 0.00 |
| Total | +0.00 | -$3.29K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
584.00 shares
Shares
−584.00
Strike price
9.5671
Held after
5.84K
Exercisable
—
1/11/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares584.00 shares | 1/11/2021 | M · Option Exercise | −584.00 | 9.5671 | — | 5.84K |